Werewolf Therapeutics Share Price Today
(NASDAQ: HOWL)

Name: Werewolf Therapeutics Share Price (NASDAQ: HOWL) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Werewolf Therapeutics share price is $0.88 & ₹75.24 as on 9 May 2025, 2.30 'hrs' IST

$0.88

▲

-0.04

(-4.45%)

Market is closed - opens 7 PM, 09 May 2025

View live Werewolf Therapeutics share price in Dollar and Rupees. Guide to invest in Werewolf Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Werewolf Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Werewolf Therapeutics share price movements

Today's Low: $0.86
Today's High: $0.92
$0.88
2.27%
Downside
Day's Volatility :6.62%
Upside
4.45%
52 Weeks Low: $0.60
52 Weeks High: $5.73
$0.88
32.39%
Downside
52 Weeks Volatility :89.62%
Upside
84.64%

Werewolf Therapeutics (HOWL) Returns

Period	Werewolf Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-35.29%	-7.6%	0.0%
6 Months	-61.74%	-9.9%	0.0%
1 Year	-84.2%	-5.6%	0.0%
3 Years	-85.28%	7.0%	0.4%

Werewolf Therapeutics (HOWL) Key Statistics

in dollars & INR

Previous Close	$0.921
Open	$0.921
Today's High	$0.921
Today's Low	$0.86
Market Capitalization	$42.6M
Today's Volume	$172.4K
52 Week High	$5.73
52 Week Low	$0.595
Revenue TTM	$1.9M
EBITDA	$-71.8M
Earnings Per Share (EPS)	$-1.63
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-76.33%

How to invest in Werewolf Therapeutics Stock (HOWL) from India?

It is very easy for Indian residents to invest directly in Werewolf Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Werewolf Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Werewolf Therapeutics or HOWL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Werewolf Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Werewolf Therapeutics shares which would translate to 0.972 fractional shares of Werewolf Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Werewolf Therapeutics, in just a few clicks!

Returns in Werewolf Therapeutics (HOWL) for Indian investors in Rupees

The Werewolf Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Werewolf Therapeutics investment value today

Current value as on today

₹18,203

Returns

₹81,797

(-81.8%)

Returns from Werewolf Therapeutics Stock

₹84,201 (-84.2%)

Dollar Returns

₹2,404 (+2.4%)

Indian investors sentiment towards Werewolf Therapeutics (HOWL)

31%

Period: Apr 8, 2025 to May 8, 2025. Change in 30 Days versus previous period

Search interest for Werewolf Therapeutics Stock from India on INDmoney has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Werewolf Therapeutics

RA Capital Management, LLC
13.69%
Mpm Asset Management, LLC
9.55%
Partner Fund Management LP
6.47%
MPM Oncology Impact Management LP
5.32%
Bank of America Corp
4.63%
BlackRock Inc
3.79%

Analyst Recommendation on Werewolf Therapeutics

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Werewolf Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Werewolf Therapeutics Stock (HOWL)

What analysts predicted

Upside of 1055.31%

Target:

$10.17

Current:

$0.88

Insights on Werewolf Therapeutics Stock (Ticker Symbol: HOWL)

Price Movement
In the last 1 month, HOWL stock has moved up by 28.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 742.0K → 1.14M (in $), with an average increase of 35.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -16.67M → -20.4M (in $), with an average decrease of 22.4% per quarter
HOWL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 82.8% return, outperforming this stock by 166.3%
HOWL vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.8% return, outperforming this stock by 208.7%
Price to Sales
ForHOWL every $1 of sales, investors are willing to pay $20.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Werewolf Therapeutics Technicals Summary

Sell

Neutral

Buy

Werewolf Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Werewolf Therapeutics (HOWL) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Werewolf Therapeutics Inc	22.27%	-61.74%	-84.2%	-85.28%	-94.53%
Regeneron Pharmaceuticals, Inc.	-5.1%	-33.93%	-43.46%	-11.02%	-4.67%
Beone Medicines Ltd	12.71%	14.87%	39.96%	64.27%	44.57%
Vertex Pharmaceuticals Incorporated	-10.78%	-16.72%	2.7%	79.18%	50.84%
Alnylam Pharmaceuticals, Inc.	6.4%	-6.7%	71.0%	101.94%	81.73%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Werewolf Therapeutics Inc	0.66	NA	NA	-1.74	-0.76	-0.3	NA	1.64
Regeneron Pharmaceuticals, Inc.	15.39	15.39	1.3	35.79	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.06	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.37	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.07	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Werewolf Therapeutics Inc	Buy	$40.6M	-94.53%	0.66	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$65.4B	-4.67%	15.39	31.94%
Beone Medicines Ltd	NA	$29.5B	44.57%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.8B	50.84%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.6B	81.73%	NA	-11.49%

About Werewolf Therapeutics

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. The company's lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Organization	Werewolf Therapeutics
Employees	46
CEO	Dr. Daniel J. Hicklin Ph.D.
Industry	Services

Management People of Werewolf Therapeutics

Name	Title
Dr. Daniel J. Hicklin Ph.D.	Founder, CEO, President, Secretary & Director
Mr. Timothy W. Trost CPA	CFO, Treasurer & Assistant Secretary
Dr. Randi Isaacs M.D.	Chief Medical Officer
Dr. William Winston Ph.D.	Senior Vice President of Research
Dr. Chulani Karunatilake Ph.D.	Chief Technology Officer
Mr. Steven H. Bloom R.Ph.	Chief Business Officer

Important FAQs about investing in HOWL Stock from India :

What is Werewolf Therapeutics share price today?

Werewolf Therapeutics share price today stands at $0.88, Open: $0.92 ; Previous Close: $0.92 ; High: $0.92 ; Low: $0.86 ; 52 Week High: $5.73 ; 52 Week Low: $0.60.

The stock opens at $0.92, after a previous close of $0.92. The stock reached a daily high of $0.92 and a low of $0.86, with a 52-week high of $5.73 and a 52-week low of $0.60.

Can Indians buy Werewolf Therapeutics shares?

Yes, Indians can invest in the Werewolf Therapeutics (HOWL) from India.

With INDmoney, you can buy Werewolf Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Werewolf Therapeutics at zero transaction cost.

How can I buy Werewolf Therapeutics shares from India?

It is very easy to buy Werewolf Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Werewolf Therapeutics (HOWL) be purchased?

Yes, you can buy fractional shares of Werewolf Therapeutics with INDmoney app.

What are the documents required to start investing in Werewolf Therapeutics stocks?

To start investing in Werewolf Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.